Family cancer syndrome is defined as a genetic change that significantly increases the risk of cancer running in a family. Hereditary cancer testing benefits you and other family members.

At Novo Genomics, we test for several types of hereditary cancer syndromes, including but not limited to familial adenomatous polyposis, familial breast and ovarian cancer, familial retinoblastoma, Fanconi anemia, Lynch syndrome (hereditary nonpolyposis colorectal cancer), multiple endocrine neoplasia type 2, MUTYH-associated polyposis, and Neurofibromatosis type 1

Breast cancer is the most common malignancy among Arab women, with 3 in 10 females developing breast cancer.

Novo genetic breast cancer identifies women as more likely to develop breast cancer due to genetic factors and provides detailed screening recommendations to keep them healthy.

Our unique approach to genetic breast cancer can also guide women who have already developed breast cancer to choose the best treatment option based on their genetic makeup (personalized cancer treatment).it enables us to investigate more than 28 genes linked to hereditary breast cancer

Colorectal cancer (CRC) is a condition in which cells in the colon or rectum divide uncontrollably. For short, it is known as colon cancer.

It is the third most prevalent cancer and the second major cause of cancer deaths globally. CRC has increased worldwide, particularly in the younger population, with new cases expected to increase among 20-49-year-olds by 2030.

CRC is becoming more common among young people in the Middle East and other parts of the world.

Our unique approach enables us to investigate more than 23 genes that have been linked to colon and rectal cancer.

Lung cancer is the most common cause of mortality from cancer globally.

Lung cancer kills more people each year than breast, colon, and prostate cancer collectively.

There are several risk factors for lung cancer, including smoking, exposure to radon gas, secondhand smoke, and air pollution, The fact is that anyone can develop lung cancer.

Our unique approach enables us to investigate more than five genes that have been linked to colon and rectal cancer.